While aberrant expression of PRMT5 favors transformation and tumor growth in a range of hematologic as well as solid and soft tissue neoplasms14–17, the events causing PRMT5 deregulation during cellular transformation remain largely uncharacterized. This evidence concerns the gene PRMT5 and neoplasm.